SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019231-16-000024
Filing Date
2016-02-12
Accepted
2016-02-12 12:54:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 Ziopharm.htm SC 13G/A 11288
2 Ziopharm.pdf SC 13G/A 280195
  Complete submission text file 0001019231-16-000024.txt   398743
Mailing Address 401 CONGRESS AVENUE, SUITE 2800 AUSTIN TX 78701
Business Address 401 CONGRESS AVENUE, SUITE 2800 AUSTIN TX 78701 5122251630
UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO (Filed by) CIK: 0001019231 (see all company filings)

IRS No.: 742765082 | State of Incorp.: TX | Fiscal Year End: 0831
Type: SC 13G/A

Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Subject) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79364 | Film No.: 161417102
SIC: 8093 Services-Specialty Outpatient Facilities, NEC